
Sanjay Kukreja
Get their honest, personalized take on your startup.
Sign in to pitch Sanjay →At a glance
- Full Name
- Sanjay Kukreja
- Title
- Managing Partner; Chief Investment Officer
- Firm
- ChrysCapital
- Firm Type
- Private equity
- Investment Stage
- Growth equity, control investments, buyouts, pre-IPO/private equity
- Target Company Profile
- Established, high-growth companies in high-ROCE sectors that are open to working with investors as agents of change
- Sector Focus
- Enterprise technology, financial services, healthcare/pharma, consumer, new economy, manufacturing
- Geographic Focus
- India-focused private equity, with selective cross-border enterprise-technology exposure
- Location
- Greater Delhi Area, India
Background
Sanjay Kukreja is Managing Partner and Chief Investment Officer at ChrysCapital, one of India’s largest and longest-running homegrown private equity firms. ChrysCapital says he has been with the firm since April 2000 and manages overall investment strategy and portfolio construction. The firm’s history also identifies Kukreja, Kunal Shroff, and Ashley Menezes as among its earliest hires around ChrysCapital’s 1999 founding.
Kukreja was elevated to Managing Partner in 2026, after serving as Partner and CIO. In ChrysCapital’s announcement, Kunal Shroff credited him with shaping the firm’s investment philosophy, portfolio construction, and long-term value creation, and said he had led several of the firm’s most successful investments.
His education includes an MBA from the Indian Institute of Management Bangalore and a BA in Economics from Delhi University. Xoriant’s leadership profile also lists him as a board member or director connected with Xoriant, Hero FinCorp, Intas Pharma, ResultsCX, GeBBS Healthcare, ChrysCapital Advisors LLP, and Nuvo ChrysCapital Advisors Pvt. Ltd.; LinkedIn also lists board roles at Livguard Batteries, Infogain, LiquidHub, KPIT Technologies, and Shriram Transport.
Investment Thesis & Focus
- ChrysCapital’s stated investment philosophy is to find “best-in-class companies in high-growth, high-ROCE sectors” that are open to investor partnership and change.
- Kukreja’s strategy centers on enterprise tech, pharma/healthcare, consumer, and financial services; in a 2025 Moneycontrol interview, he said these four sectors account for roughly 80% to 90% of ChrysCapital fund deployment.
- The firm invests with a 5-7 year horizon and evaluates both growth and control investments through a disciplined risk-versus-reward lens.
- ChrysCapital has increasingly moved into control and joint-control transactions: Kukreja said the firm moved from almost no control deals in its first decade to about half of its latest fund being control or joint-control.
- For new-economy companies, Kukreja described the approach as opportunistic and generally consumer-oriented, rather than broad early-stage venture investing.
- In consumer, Kukreja has emphasized brands with growth, management quality, margin-improvement potential, international potential, and attractive risk/reward.
Notable Investments
- Theobroma: ChrysCapital acquired about an 85% stake in the premium bakery and QSR brand in 2025, its first consumer-sector buyout.
- Novartis India: In February 2026, Novartis AG agreed to transfer its 70.68% stake in Novartis India to a ChrysCapital-led group, marking ChrysCapital’s first majority buy in Indian pharma.
- Xoriant: Digital product engineering, cloud, security, data, and enterprise services company; Kukreja is listed on Xoriant’s leadership page as Partner & CIO of ChrysCapital and a board member.
- Hero FinCorp: Financial-services company; Kukreja is listed as a board member on LinkedIn and by Xoriant.
- Intas Pharmaceuticals: Major Indian pharma company; Kukreja is listed as a board member, and ChrysCapital identifies Intas as a current healthcare investment.
- GeBBS Healthcare Solutions: Healthcare revenue-cycle-management company; Xoriant lists Kukreja as serving on its board.
- ResultsCX: Customer-experience services provider; LinkedIn and Xoriant list Kukreja as a board member.
- LiquidHub: Digital transformation and IT architecture consulting firm; LinkedIn lists Kukreja as a former board member, and ChrysCapital sold LiquidHub to Capgemini in 2018.
- KPIT Technologies: Automotive engineering, embedded software, ERP, and BI services company; LinkedIn lists Kukreja as a former board member.
- Infogain: Front-end, customer-facing technology services company; LinkedIn lists Kukreja as a former board member, and ChrysCapital exited the control investment to Apax in 2021.
Unlock the full research
Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.
One-time. Stays unlocked for you.